Herbalife price target raised to $11 from $10 at Mizuho

Mizuho analyst John Baumgartner raised the firm’s price target on Herbalife (HLF) to $11 from $10 and keeps a Neutral rating on the shares. The firm believes the company’s fundamentals remain on a “recovery path.” Herbalife’s evolution under new CEO Stephan Gratziani is “increasingly encouraging,” the analyst tells investors in a research note. Mizuho says a return to corporate volume growth is possible in fiscal 2026. It upped estimates for Herbalife.